Covidien to put at least $50M in new drug-coated balloon acquisition December 31, 2012 By MassDevice staff Leave a Comment Massachusetts medical device company Covidien (NYSE:COV) signed a definitive agreement to acquire drug-coated balloon maker CV Ingenuity, planning to put millions toward R&D over the next 2 years.